Glowide Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Glowide Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, gr…

2016-02-26 Nagpur, Maharashtra Active Unlisted Active Compliant
Share
GP Glowide Pharmaceuticals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Glowide Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
73/100
Trust Score
Moderate

Glowide Pharmaceuticals Private Limited is assessed as Moderate with a Trust Score of 73/100. Glowide Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2016, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 19 Jul 2026 from the latest processed filings. Glowide Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
73/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
35/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 35/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 3 open (78.00 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Bank Of India3 48.0 cr
Compliance Score: 68/100 Moderate
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2020 - filings overdue.
  • Litigation present in 1 court forum(s).
  • 2 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MANISH HADKE VINAYAKRAO 01234567 Director 01/04/2018 6 yrs Approved
PRASHANT VINYAKRAO HADKE 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: PRASHANT VINYAKRAO HADKE (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 55
Growth signals & trust indicators
Asset base grew 1.42 - capacity expansion.
Net margin improved to 2.1x.
EPFO headcount growing - hiring signal.
Operating for 10+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Outside liabilities up 24% in a year.
Statutory filings appear overdue.
3 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence66/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment51/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 78.00 Lakh already registered.
  • Compliance gaps should be priced into terms.
Investor view65/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 14 events
31 Dec 2020
Last AGM held
Annual general meeting
08 Jul 2020
Charge created
Bank Of India - 12.00 Lakh
01 Jul 2020
Charge created
Bank Of India - 6.00 Lakh
24 Jun 2020
Director ceased
MOHAN GOVINDRAO KEKATPURE
31 Mar 2020
Latest balance sheet
Filed with ROC
06 Feb 2019
Securities allotted
90000 Equity Shares Without Differential Rights - 9.00 Lakh raised
27 Aug 2018
Securities allotted
114000 Equity Shares Without Differential Rights - 11.40 Lakh raised
30 Jul 2018
Director ceased
PRASHANT VINYAKRAO HADKE
23 Jan 2018
Securities allotted
80000 Equity Shares Without Differential Rights - 8.00 Lakh raised
22 Jan 2018
Securities allotted
80000 Equity Shares Without Differential Rights - 8.00 Lakh raised
10 Aug 2017
Charge created
Bank Of India - 60.00 Lakh
26 Feb 2016
Incorporated
Registered with Roc Mumbai
Director appointed
MANISH HADKE VINAYAKRAO (Director)
Director appointed
PRASHANT VINYAKRAO HADKE (Managing Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 0.86 - leverage worth monitoring.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Shinesurface Chemicals Private Limited U46691PN2018PTC181077 Pune City, Maharashtra, India
Sun Agro Biosystem Private Limited U52397TN2001PTC047109 Chennai - 600 116., Tamil Nadu, India
Manna Chemicals And Drugs Private Limited U24240TN2013PTC091906 Chennai, Tamil Nadu, India
Samridhi Biotech Private Limited U24233DL2006PTC150486 New Delhi, Delhi, India
Jiomed Healthcare Private Limited U74999TG2017PTC115054 Hyderabad, Telangana, India
Ran Multi Services Private Limited U74120UP2015PTC070732 Lucknow, Uttar Pradesh, India
Suvarna Additives Private Limited U24100MH2011PTC221076 Navi Mumbai, Maharashtra, India
Abenava Medipharma Private Limited U74999UP2012PTC048369 Agra, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Glowide Pharmaceuticals Private Limited before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Glowide Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 35/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 65/100, margin trends, ownership structure and peer set for Glowide Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 73/100, distress signals and MSME payment-delay disclosures - know whether Glowide Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Glowide Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Glowide Pharmaceuticals Private Limited an active company?

Glowide Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 68/100 (Moderate).

Is Glowide Pharmaceuticals Private Limited financially healthy?

Glowide Pharmaceuticals Private Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Glowide Pharmaceuticals Private Limited?

Its overall Trust Score is 73/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Glowide Pharmaceuticals Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Glowide Pharmaceuticals Private Limited have loans or charges against its assets?

3 open charge(s) are registered against its assets.

Is Glowide Pharmaceuticals Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2020 - filings overdue. Overall compliance score: 68/100 (Moderate).

Is it risky to lend to Glowide Pharmaceuticals Private Limited?

Its Credit Risk Score is 35/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.